Whitney Shatz-Binder

Company: Genentech

Job title: Principal Scientist

Seminars:

Roundtable Discussion: Improving on Animal Models: Modern Screening Methods in Nasal Drug Development 1:30 pm

Highlighting the challenges posed by small animals in nasal drug development and the need for alternatives with more translatability Comparing a range of promising options, including 3D organoids, lab-grown nasal epithelia, 3D printed models, nasal cast models, and primate models Examining the remaining issues associated with these substitutes, such as the metabolism of nasal casts…Read more

day: Conference Day Two

Harnessing the Potential of Nasal Drug Delivery with Nanoparticle Formulation 9:00 am

Delving into the hurdles when formulating to bypass the blood-brain barrier via nasal drug delivery Analyzing differences in dose, bioavailability and target tissue based on particle size and molecule type on drug efficacy Highlighting the achievements of novel functionalized nanocarriers and reviewing possible future applicationsRead more

day: Conference Day One